While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

If you have questions about Wegovy, talk with your doctor or pharmacist. Wegovy is a prescription injection used for weight management and to lower the risk of cardiovascular problems. Like most ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Rs 14,000 a month—for weight loss.But, but, but… India’s obesity problem is no small fry, and Big Pharma is racing to cash in ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Eli Lilly expands its diabetes and weight-loss drug, Mounjaro, to India, outpacing Novo Nordisk. The drug is priced ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...